Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation‐Associated Intracerebral Hemorrhage
Regina Royan(University of Michigan), Kevin N. Sheth(MIND Research Institute), Nicole Solomon(Clinical Research Institute), Ilya Danelich(AstraZeneca (South Korea)), Brian Mac Grory(Duke University), Adam H de Havenon(Yale University), Raymond Chuen‐Chung Chang(AstraZeneca (United States)), Joanna Huang(AstraZeneca (South Korea)), Ying Xian(Southwestern Medical Center), Steven R. Messe(California University of Pennsylvania), Jeffrey L. Saver(University of California, Los Angeles), Lee H. Schwamm(Yale University), Joshua N. Goldstein(Massachusetts General Hospital), Gregg C. Fonarow(University of California, Los Angeles), Eric E. Smith(University of Calgary), Brian Stamm(University of Michigan), Deepak L. Bhatt(Mount Sinai Medical Center), Brooke Alhanti(Clinical Research Institute)
Cited by 1
Related Papers
SARS-CoV-2 and Stroke in a New York Healthcare System
|Stroke|2020|751
Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association
|Stroke|2021|293
TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage
|Journal of Clinical Investigation|2016|279
Kidney Function and Outcomes in Patients Hospitalized With Heart Failure
|Journal of the American College of Cardiology|2021|196
The beneficial effects of physical exercise in the brain and related pathophysiological mechanisms in neurodegenerative diseases
|Laboratory Investigation|2019|152